Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 1
Submit an article Journal homepage
1,268
Views
7
CrossRef citations to date
0
Altmetric
Brief Report

Prophylactic vaccination targeting ERBB3 decreases polyp burden in a mouse model of human colorectal cancer

David J. BautzDepartment of Genetics, North Carolina State University, Raleigh, NC, USA
,
Ang T. SherpaDepartment of Genetics, North Carolina State University, Raleigh, NC, USA
&
David W. ThreadgillDepartment of Veterinary Pathobiology, Department of Molecular and Cellular Medicine, Texas A&M University, College Station, TX, USACorrespondence[email protected]
Article: e1255395 | Received 03 Aug 2016, Accepted 26 Oct 2016, Published online: 11 Jan 2017

References

  • Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-5; PMID:1651562; http://dx.doi.org/10.1126/science.1651562
  • Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spiro L, Robertson M et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66:589-600; PMID:1651174; http://dx.doi.org/10.1016/0092-8674(81)90021-0
  • Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009; 22:198-208; PMID:21037810; http://dx.doi.org/10.1055/s-0029-1242459
  • Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995; 31:1061-4; http://dx.doi.org/10.1016/0959-8049(95)00181-H; PMID:7576992
  • Lee D, Yu M, Lee E, Kim H, Yang Y, Kim K, Pannicia C, Kurie JM, Threadgill DW. Tumor-specific apoptosis caused by deletion of the ERBB3 psuedo-kinase in mouse intestinal epithelium. J Clin Invest 2009; 119:2702-13; PMID:19690388; http://dx.doi.org/10.1172/JCI36435
  • Sithanandam G, Anderson LM. The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther 2008; 15:413-48; PMID:18404164; http://dx.doi.org/10.1038/cgt.2008.15
  • Cho HS, Leahy DJ. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 2002; 297:1330-3; PMID:12154198; http://dx.doi.org/10.1126/science.1074611
  • Buac K, Watkins-Chow DE, Loftus SK, Larson DM, Incao A, Gibney G, Pavan WJ. A Sox10 expression screen identified an amino acid essential for Erbb3 function. PLoS Genet 2008; 4:e1000177; PMID:18773073; http://dx.doi.org/10.1371/journal.pgen.1000177
  • Liu S, Toblas R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 1997; 30:455-63; PMID:9316739; http://dx.doi.org/10.1016/S0009-9120(97)00049-0
  • Roberts RB, Min L, Washington MK, Olsen SJ, Settle SH, Coffey RJ, Threadgill DW. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci USA 2002; 99:1521-6; PMID:11818567; http://dx.doi.org/10.1073/pnas.032678499
  • Van de Perre P. Transfer of antibody via mother's milk. Vaccine 2003; 21:3374-6; PMID:12850343; http://dx.doi.org/10.1016/S0264-410X(03)00336-0
  • Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, Moore MW. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice. Development 1997; 124:4999-5011; PMID:9362461.
  • Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, Cotsarelis G, Zediak VP, Velez M, Bhandoola A, Brown EJ. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem-cell loss. Cell Stem Cell 2007; 1:113-26; PMID:18371340; http://dx.doi.org/10.1016/j.stem.2007.03.002
  • Jaini R, Kesaraju P, Johnson JM, Altunas CZ, Jane-wit D, Tuohy VK. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 2010; 16:799-803; PMID:20512124; http://dx.doi.org/10.1038/nm.2161
  • Disis ML, Gralow JR, Bernhard H, Hand SL, Rubin WD, Cheever MA. Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein. J Immunol 1996; 156:3151-8; PMID:8617935
  • Stancovski I, Hurwitz E, Leitner O, Ullrich A, Yarden Y, Sela M. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc Natl Acad Sci USA 1991; 88:8691-5; PMID:1717984; http://dx.doi.org/10.1073/pnas.88.19.8691
  • Aurisicchio L, Marra E, Roscilli G, Mancini R, Ciliberto G. The promise of anti-ErbB3 monoclonals as new cancer therapeutics. Oncotarget 2012; 3:744-58; PMID:22889873; http://dx.doi.org/10.18632/oncotarget.550
  • Xiao Z, Carrasco RA, Schifferli K, Kinneer K, Tammali R, Chen H, Rothstein R, Wetzel L, Yang C, Chowdhury P, Tsui P, Steiner P, Jallal B, Herbst R, Hollingsworth RE, Tice DA. A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response. Mol Cancer Ther 2016; 15:689-701; PMID:26880266; http://dx.doi.org/10.1158/1535-7163.MCT-15-0555

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.